This year alone, their Olstein Strategic Opportunities Fund has seen
two of its holdings targeted by activists and another six the object
of announced acquisitions. That's a significant showing for a fund
with a smallish $116 million portfolio.
Those kind of market events generally drive big gains in a stock's
price, and the fund's ability to be there first has rewarded
shareholders. Over three years its returns have been double those of
the average activist hedge fund, making its portfolio one for
bargain hunters to watch.
Heyman and Olstein, who ran his own stock research service in the
1960s, have a simple explanation for their success: it's all about
the balance sheet.
“A lot of people look at these businesses and treat them as stocks,”
Heyman said in an interview. “We look at it as if we are a private
equity company and we are buying the business.”
Over the five years ended Sept. 30, outside activists like Jana
Partners, Relational Investors and Nelson Peltz of Trian Partners
have invested in nine of the companies that are among Olstein's
portfolio holdings; none would comment for this story.
"We think there are some pretty smart people monitoring our
portfolio," the 73-year-old Olstein told Reuters.
Heyman and Olstein look for small-cap companies that have stumbled
but offer solid management, turnaround prospects and the ability to
produce free cash flow.
Those metrics have brought them to companies like CareFusion, a top
holding of the fund that recently agreed to be acquired by Becton
Dickinson & Co in a deal that valued the company at a 26 percent
premium to its last closing share price. In July, when hedge fund
Jana Partners announced its activist stake in PetSmart Inc, the
Olstein fund was already sitting on 69,000 shares, according to
Lipper.
The fund also holds nutritional supplement retailer Vitamin Shoppe,
which is the subject of shareholder and activist calls for a sale.
AN AVENUE FOR INDIVIDUAL INVESTORS
As of Sept. 30, the Olstein fund had a three-year annualized return
of 26.48 percent, while the Activist Hedge Fund Index had an
annualized return of 13.16 percent.
"For individual investors who cannot afford to invest with the hedge
fund activists, this is a way to own shares of the companies many
are targeting," said Todd Rosenbluth, director of mutual fund
research at S&P Capital IQ.
[to top of second column] |
The Olstein fund is expensive, with management fees of 1.60 percent,
and certain share classes carry sales charges. It is, however,
cheaper than activist hedge funds, which tend to charge management
fees around 1.75 percent plus incentive fees.
The fund has not escaped this year's stock market selloff. It is
down 2.24 percent through Oct. 10, compared with the 7.44 percent
average decline for Lipper's category of small cap core funds.
There is one consumer fund that is solely focused on activists'
targets, the 13D Activist Fund, but it buys companies after they
have been targeted. The fund returned 0.71 percent this year through
Oct. 10.
But for Olstein and Heyman, value is not defined by activists'
interests. They still hold audio equipment maker Harman
International Industries, five years after buying the stock and two
years after it was targeted by Relational Investors.
Similarly, Heyman and Olstein are sticking with all-terrain vehicle
maker Arctic Cat, which recently fired its chief executive officer.
At roughly $32 a share, the stock is down 44 percent this year but
Heyman and Olstein believe the company could become a $45 stock with
a new CEO.
Olstein's process does not always work. In 2011, the fund was down
7.6 percent, compared with an average decline of 3.4 percent for
small-cap core funds, according to Lipper.
Olstein and Heyman themselves have behaved like activists in only a
handful of situations, usually behind the scenes, and said they
never engage with hedge fund activists.
"I have no desire to be the next Carl Icahn," Olstein said. "Carl
knows how to take over companies, I know how to value them."
(Reporting by Jessica Toonkel; Editing by Linda Stern and Leslie
Adler)
[© 2014 Thomson Reuters. All rights
reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |